| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a48132fcc2f50a7107021f911f887cb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-811 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12 |
| filingDate |
1997-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5f1eed9943c3387faee8a09655be7f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f99ad8a692b988327f59df8cb19da9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb92fa774581691c83f26bad96fd5ac3 |
| publicationDate |
2000-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20000048981-A |
| titleOfInvention |
Hormonal composition consisting of an oestrogen compound and of a progestational compound |
| abstract |
The present invention relates to the field of chemical therapy, in particular to the field of pharmaceutical hormone technology.n n n More specifically, the present invention provides that an estrogen progesterone combination capable of simultaneous administration of an estrogen component and a progesterone component is formed by combining or mixing with one or more pharmaceutically acceptable excipients which are inert and nontoxic, and are administered orally A pharmaceutical estroprogesterone composition characterized by the above. The invention also relates to a method of using an estroprogesterone composition in which the estrogen component and the progesterone component are administered in a combined form. To treat estrogen deficiency occurring in postmenopausal women, to prevent osteoporosis and cardiovascular disease, or to block ovulation in women during ovarian activity, the estroprogesterone composition can be administered continuously or intermittently. The invention also relates to a process for preparing such novel estroprogesterone compositions. |
| priorityDate |
1996-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |